Shilpa Kadam
About Shilpa Kadam
Shilpa Kadam is a Principal Scientist at Bristol-Myers Squibb in New Jersey, United States, where she leads a team focused on cancer target discovery and validation.
Current Role at Bristol-Myers Squibb
Shilpa Kadam holds the position of Principal Scientist at Bristol-Myers Squibb in New Jersey, United States. She has been with the company since February 2015. In her current role, she leads a team focused on cancer target discovery and validation. She has played a critical role in initiating full drug discovery efforts for several validated targets. Her work also involves cancer target validation and devalidation, contributing significantly to the company's oncology research initiatives.
Previous Experience at Novartis
Before joining Bristol-Myers Squibb, Shilpa Kadam worked at Novartis as a Project Team Lead from 2009 to 2015. During her six-year tenure in Basel, Basel-city, Switzerland, she led project teams and was involved in various critical projects. Her experience at Novartis contributed to her expertise in the pharmaceutical industry and project leadership.
Research Associate at Salk Institute
Shilpa Kadam served as a Research Associate at the Salk Institute for Biological Studies in La Jolla, California, United States, from 1998 to 2004. During her six years at the institute, she engaged in important research activities that laid the groundwork for her subsequent contributions in the field of biological sciences.
Educational Background
Shilpa Kadam completed her Doctor of Philosophy (PhD) in Biology at the University of Mumbai from 1994 to 1998. Prior to her doctorate, she achieved a Master of Science (MSc) in Microbiology from the same university, studying from 1992 to 1994. Her strong educational foundation has played a key role in her professional achievements in the fields of biology and oncology research.